New Trends in Migraine Pharmacology: Targeting Calcitonin Gene–Related Peptide (CGRP) With Monoclonal Antibodies

New Trends in Migraine Pharmacology: Targeting Calcitonin Gene–Related Peptide (CGRP) With Monoclonal Antibodies

Migraine is a common neurologic disorder characterized by attacks consisting of unilateral, throbbing headache accompanied by photophobia, phonophobia, and nausea which remarkably reduces the patients’ quality of life. Not migraine-specific non-steroidal anti-inflammatory drugs (NSAIDs) are effectiv...

Full description

Bibliographic Details
Main Authors: Damiana Scuteri, Annagrazia Adornetto, Laura Rombolà, Maria Diana Naturale, Luigi Antonio Morrone, Giacinto Bagetta, Paolo Tonin, Maria Tiziana Corasaniti
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-04-01
Series:Frontiers in Pharmacology
Subjects:
migraine
pharmacology of migraine
CGRP
treatment
anti-CGRP
monoclonal antibodies anti-CGRP
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2019.00363/full

Internet

https://www.frontiersin.org/article/10.3389/fphar.2019.00363/full

Similar Items